baber/WOPTO huggingface dataset:
Patent NZ-568451-A (NZ)
Title: Parking system employing remote asset management techniques
Inventor: GROFT ERIC G
IPC: H04M11/00
Filed: 2008-05-21
Abstract: An integrated parking management system (IPMS) is provided. The IPMS includes: a central command and control logic center (CCLC) for collecting, storing and analyzing data received from remote locations in the parking system to create actionable outputs for controlling remote parking system components (RPSC) in the parking system (PS), where the CCLC communicates with the RPSC and receives feedback from the RPSC to perform requested operations from the RPSC; a computerized data flow system forming a command and control interface (CCI) and including a logic core having a programmable set of rules to be applied to the RPSG components and a communications interface layer (CIL) including (1) a presentation engine for generating interactive documents for display, and (2) means for enabling exchange of data streams to the RPSC and (3) routing tables for tracking both the means and protocols to be used when the CCI is communicating with the RPSC; the communication interface layer receives data to be transmitted and a parking system component address to which data is to be transmitted; and at least some of the RPSC transmitting data via the CCI to the CCLC representing the status of the parking system and receiving instructions from the CCLC via the CCI for controlling the operation of the parking system.
Patent NZ-568776-A (NZ)
Title: Crystalline forms of 1-benzoyl-4-[2-[4-methoxy-7-(3-methyl-1H-1,2,4-triazol-1-yl)-1-[(phosphonooxy)methyl]-1H-pyrrolo[2,3-c]pyridin-3-yl]-1,2-dioxoethyl]-piperazine
Inventor: CHEN CHUNG-PIN H
IPC: A61K31/437
Filed: 2006-12-13
Abstract: Disclosed is a crystalline form of the pictured compound, 1-benzoyl-4-[2-[4-methoxy-7-(3-methyl-1H-1,2,4-triazol-1-yl)-1-[(phosphonooxy)methyl]-1H-pyrrolo[2,3-c]pyridin-3-yl]-1,2-dioxoethyl]-piperazine, which is a hemiethanolate octahydrate di-sodium salt of the compound and has an x-ray diffraction pattern as described in the specification. The specification also describes other crystalline forms of the same compound.
Patent NZ-569975-A (NZ)
Title: High speed watercraft suitable for rough water conditions, with forward and rear lateral hull units jointed to central platform body for vertical motion
Inventor: MEYER THOMAS WILMOT
IPC: B63B1/22
Filed: 2005-12-23
Abstract: A watercraft suitable for operation in rough water conditions is disclosed. The watercraft comprises a central platform (12) and two pairs of hull units (29,61), a forward pair and an aft pair. The hull units are located on opposite sides of the platform and extend below the platform, with each hull unit comprising a mount attached to the platform and a trailing hull connected to the mount via a movable hull support. The components of the hull units are connected by joints arranged to constrain lateral and axial movement of: the hull relative to the platform (12) but to permit pivoting thereof about the mount. Each hull unit has a suspension assembly arranged to support the respective hull units, and comprises a suspension member extending from the platform (12) to a mounting point on the hull aft of the respective mount, and being arranged to accommodate movement of the hull relative to the platform and to apply damping to movement of the hull.
Patent NZ-570673-A (NZ)
Title: Vibrational apparatus
Inventor: PFAHLERT ROGER
IPC: B25D9/02
Filed: 2005-12-14
Abstract: A vibrational apparatus, capable of providing a vibrational output as a consequence of controllable relative rotation between a shuttle and its complement, where the shuttle carries first and second magnetic arrays, each about the shuttle axis, is disclosed. An input drive causes relative rotation between the shuttle and its complement. As a result of the input, and thus the relative rotation, shuttling occurs as a consequence of interactions and out of phase interactions of the first and second pairing of magnetic arrays of the shuttle and first and second magnetic arrays of the complement. As a consequence of the relative rotation and the shuttling of the shuttle relative to its complement a vibrational output is generated which is passed axially of the shuttle axis into apparatus associated with the vibrational apparatus.
Patent NZ-570897-A (NZ)
Title: Duvet cover
Inventor: TEPPER HELEN JANE
Filed: 2008-08-29
Abstract: A duvet cover (10) including an envelope portion (20) substantially closable for enveloping a duvet to shield the duvet from soiling is disclosed. The envelope portion is removable from the duvet for laundering. The duvet cover further includes a sheet portion (30) attachable to the envelope portion to underlie the envelope portion to shield the underside (21) of the envelope portion from soiling. The sheet portion is removable from the envelope portion for laundering. A method of minimising duvet cover laundering requirements is also provided.
Patent NZ-575580-A (NZ)
Title: Scaffolding connection system
Inventor: KRELLER HELMUT
IPC: E04G1/14
Filed: 2007-10-05
Abstract: A vertical frame made of metal, particularly a scaffolding frame, having at least one first vertical shaft (21) and a bar-shaped, horizontal transversal arm (23) extending away from the same, the shaft and arm being permanently connected to each other. A first perforated disk having a plurality of openings is permanently mounted to the shaft, the perforated disk surrounding the shaft in a flange-like manner. At least one first mounting device is provided on the shaft at a distance to the perforated disk for mounting a fall-protection means. The transversal arm has on one end thereof a first connecting head, and on the second end thereof facing away from the first end a second connecting head by means of which the transversal arm can be secured on a second vertical shaft via a second perforated disk equipped with a plurality of openings by forming a vertical frame. Each connecting head is delimited by side wall parts having vertical exterior surfaces that are tapered toward a centre n a wedge-like manner. Each connecting head has an upper head part and a lower head part. A slot that is open toward the respectively associated shaft and toward the vertical outer surfaces is provided between the upper head part and the lower head part. Each connecting head is mounted with the slot thereof on the associated perforated disk at least partially protruding into the same. Each connecting head is connected to the associated shaft and preferably also permanently connected to the associated perforated disk by means of welding.
Patent NZ-578187-A (NZ)
Title: Compositions, synthesis, and methods of using indanone based cholinesterase inhibitors
Inventor: BHAT LAXMINARAYAN
IPC: A61K31/555
Filed: 2007-12-11
Abstract: Disclosed is an indanone derivative of formula (II), (III), (IV) or (V) where an amide, ester, carbonate, phosphate, sulphate or carbamate either attached directly to the indanone or piperidine ring or is linked with a space. The other derivatives are as disclosed in the description. Also disclosed is a pharmaceutical composition comprising a compound of formula (II), (III), (IV) or (V) and the use of a compound of formula (II), (III), (IV) or (V) in the manufacture of a medicament for treating Alzheimer's disease, myasthenia gravis, Huntington's disease or glaucoma. Examples of compounds include: Ethyl 3-(( 4-((5,6-dimethoxy-1-oxo-2,3-dihydro-1H-inden-2-yl)methyl)piperidin-1-yl)methyl)benzoate; Ethyl 4-(4-(( 4-((5,6-dimethoxy-l-oxo-2,3-dihydro-1H-inden-2-yl)methyl)piperidin-1-yl)methyl)benzamido)butanoate and Isopropyl 4-((4-((5, 6-dimethoxy-l-oxo-2,3 -dihydro-1 H -inden-2-yl)methyl)piperidin-1-yl)methyl)benzoate.
Patent NZ-578677-A (NZ)
Title: AXMI-009, a delta-endotoxin gene and methods for its use
Inventor: DUCK NICHOLAS B
IPC: A01H1/00
Filed: 2004-02-20
Abstract: Compositions and methods for conferring pesticidal activity to bacteria, plants, plant cells, tissues and seeds are provided. In particular, compositions comprising a coding sequence for a delta-endotoxin polypeptide AXMI-009 derived from Bacillus thuringiensis are provided. The coding sequence can be used in DNA constructs or expression cassettes for transformation and expression in plants and bacteria.
Patent NZ-578902-A (NZ)
Title: Lotion composition for personal use
Inventor: AHMAD NAWAZ
IPC: A61K8/891
Filed: 2008-02-08
Abstract: Disclosed is a glycol-in-silicone emulsion lubricant composition comprising a discontinuous substantially anhydrous phase dispersed in a continuous oil phase, wherein said phases are mixed and homogenized, wherein the discontinuous substantially anhydrous phase comprises less than percent by weight of water, wherein the continuous oil phase comprises a linear silicone polyether, wherein the linear silicone polyether has either a rake type structure wherein the polyoxyethylene or polyoxyethylene-polyoxypropylene copolymeric units are grafted onto a siloxane backbone, or an ABA block copolymeric structure wherein A represents the polyether portion and B represents the siloxane portion of an ABA structure; wherein the continuous oil phase further comprises silicone fluids, and wherein the discontinuous substantially anhydrous phase further comprises at least one polyol, at least one salt and at least one coemulsifier.
Patent NZ-582674-A (NZ)
Title: Methods for one-pot n-demethylation/n-acylation of morphine and tropane alkaloids
Inventor: CARROLL ROBERT JAMES
IPC: C07D489/02
Filed: 2008-06-30
Abstract: Disclosed is a one pot method for the N-demethylation and N-acylation of a tertiary N-methylated heterocycle comprising reacting an N-methylated heterocycle substrate with an acylating agent reactant selected from the group consisting of an anhydride, a dicarbonate and a dicarbamic anhydride in the presence of a catalyst to obtain an N-acylated derivative product wherein the N-methylated heterocycle is a morphine alkaloid or a derivative thereof.
Patent NZ-586582-A (NZ)
Title: Spirocyclic heterocycles, medicaments containing said compounds, use thereof and method for their production
Inventor: HIMMELSBACH FRANK
IPC: C07D239/94
Filed: 2009-02-05
Abstract: Disclosed are spiro (4-(phenylamino)-quinazolin-6-yloxy)-cyclohexane derivatives as represented by the general formula (I), wherein: Ra denotes an optionally substituted phenyl or 1-phenylethyl group; A denotes >C(=O) or an optionally substituted alkylene group; and wherein the remaining substituents are as defined herein; optionally in the form of the tautomers, the racemates, the enantiomers, the diastereoisomers and the mixtures thereof, and optionally the pharmacologically acceptable acid addition salts thereof. Further disclosed is a pharmaceutical formulation which contains a compound of formula (I) as defined above, and which may be formulated for oral administration; and wherein said pharmaceutical formulation is for the treatment or prevention of an inflammatory or allergic disease of the airways, and particularly for diseases such as chronic bronchitis, acute bronchitis, bronchitis caused by bacterial or viral infection or fungi or helminths, allergic bronchitis, toxic bronchitis, chronic obstructive bronchitis (COPD), asthma (intrinsic or allergic), paediatric asthma, bronchiectasis, allergic alveolitis, allergic or non-allergic rhinitis, chronic sinusitis, cystic fibrosis or mucoviscidosis, alpha-1-antitrypsin deficiency, cough, pulmonary emphysema, interstitial lung diseases, alveolitis, hyperreactive airways, nasal polyps, pulmonary oedema, pneumonitis of different origins, etc. Representative compounds of formula (I) include syn/anti-8-[4-(3-chloro-2-fluoro-phenylamino)-7-methoxy-quinazolin-6-yloxy]-1,3-diaza-spiro[4.5]decan-2,4-dione, anti-9-[4-(3-chloro-2-fluoro-phenylamino)-7-methoxy-quinazolin-6-yloxy]-1,4-diaza-spiro[5.5]undecan-5-one, anti-9-[4-(3-chloro-2-fluoro-phenylamino)-7-methoxy-quinazolin-6-yloxy]-4-methyl-1,4-diaza-spiro[5.5]undecan-5-one, anti-9-[4-(3-chloro-2-fluoro-phenylamino)-7-methoxy-quinazolin-6-yloxy]-1,4-dimethyl-1,4-diaza-spiro[5.5]undecan-5-one and syn/anti-8-[4-(3-chloro-2-fluoro-phenylamino)-7-methoxy-quinazolin-6-yloxy]-1,3-diaza-spiro[4.5]decan-2,4-dione.
Patent NZ-587921-A (NZ)
Title: Use of a (1-3)-beta-d-glucan as an emulsion stabiliser
Inventor: LOMMERTS BERT JAN
IPC: C09K23/56
Filed: 2009-03-11
Abstract: Disclosed is an emulsion comprising 0.005 weight percent to 0.02 weight percent of a non-modified scleroglucan, based on the total weight of the emulsion. Also disclosed is the use of the emulsion in surface coating, bonding layers, dense coated materials and semi-dense coated materials which are cold-cast or storable.
Patent NZ-589053-A (NZ)
Title: Process of preparing 4-[9-(tetrahydro-furan-3-yl)-8-(2,4,6-trifluoro-phenylamino)-9h-purin-2-ylamino]-cyclohexan-1-ol compounds
Inventor: BEAUCHAMPS MARIE G
IPC: A61K31/52
Filed: 2007-10-26
Abstract: Disclosed is a process for preparing 4-[9-(tetrahydro-furan-3-yl)-8-(2,4,6-trifluoro-phenylamino-9H-purin-2-ylamino]-cyclohexan-ol, represented by general formula (I). The said process comprises the steps of; 1) substitution of 2,4-dichloro-5-nitropyrimidine with (S)-3-amino tetrahydrofuran or salt thereof; 2) further substitution with trans-4-amino cyclohexanol or salt thereof; 3) reduction of the nitro group to the corresponding amine; 4) coupling with 2,4,6-trifluorophenyl isothiocyanate; and 5) ring closure resulting in substituted purine formation.
Patent NZ-594773-A (NZ)
Title: Agomelatine hydrohalide complex and preparation method thereof
Inventor: ZHANG PENG
IPC: C07C233/18
Filed: 2010-02-26
Abstract: 594773 Disclosed herein is a hydrogen halide complex of agomelatine and a method for the preparation thereof, wherein agomelatine is reacted with HX in any form to produce the complex. More specifically wherein agomelatine is dissolved in an organic solvent before HX gas is bubbled through and the crystal is precipitated.
Patent NZ-596791-A (NZ)
Title: Food product heat treatment apparatus and method for heat treating food products
Inventor: SCHUBERT WOLFGANG
IPC: A23C3/03
Filed: 2010-05-28
Abstract: 596791 Disclosed is a food product heat treatment apparatus for the heat treatment of heat-sensitive fluid food products. The apparatus has an inlet for supplying the food product, an outlet for discharging the heat treated food product, a holding device downstream the inlet for holding the food product for a specific time at a specific temperature and a back pressure device downstream the holding device. The back pressure device comprises an externally cooled valve.
Patent NZ-598486-A (NZ)
Title: Pharmaceutical compositions methods and kit for glucocorticoid replacement therapy
Inventor: SKRTIC STANKO
IPC: A61K9/20
Filed: 2005-04-21
Abstract: Disclosed is a coated tablet dosage form for delivery of glucocorticoid replacement therapy, comprising: an extended release (ER) tablet core and an immediate release (IR) coating surrounding said tablet core; said ER core comprising hydrocortisone (HC) and an ER excipient composition composed of: a combination of hydroxypropylmethylcellulose, microcrystalline cellulose and pregelatinized starch; colloidal silicon dioxide; and magnesium stearate, the amount of HC present in said ER core being 60% to 80% of the total amount of HC present in said dosage form; said IR coating material comprising HC and at least one coating material selected from the group consisting of methylcellulose, hydroxypropylmethylcellulose, hydroxypropylcellulose, acrylic polymers, ethylcellulose, cellulose acetate phthalate, polyvinyl acetate phthalate, hydroxypropylmethylcellulose phthalate, polyvinylalcohol, sodium carobxymethylcellulose, cellulose acetate, gelatin, methacrylic acid copolymer, polyethylene glycol, shellac, sucrose, titanium dioxide, carnauba wax, microcrystalline wax, glyceryl monostearate, talc and zein, with the amount of HC present in said IR coating material being 20% to 40% of the total amount of HC present in said dosage form; and said dosage form being effective to deliver a daily dose of from about 1 to 80 mg of HC.
Patent NZ-607195-A (NZ)
Title: Methods for treating and/or reversing neurodegenerative diseases and/or disorders
Inventor: JOHE KARL K
IPC: A61K35/30
Filed: 2011-07-28
Abstract: Disclosed is the use of a therapeutically effective amount of an expanded stem cell population in the preparation of a medicament for inhibiting or relieving a disease or disorder associated with neuronal loss, wherein the expanded stem cell population is produced by expanding at least one stem cell derived from spinal cord tissue of a human to form an expanded stem cell population, wherein a therapeutically effective amount of the expanded stem cell population is introduced to at least one area of the brain of a subject.
Patent NZ-607495-A (NZ)
Title: Paper feeder and method of feeding paper
Inventor: WEBB DONALD B
IPC: D21B1/08
Filed: 2011-10-28
Abstract: 607495 A method of feeding paper through a paper feeder by conveying paper along a path and regulating the through-flow of paper from the path to dispense the paper from the feeder at a controlled flow rate while continuously moving the paper to avoid blockages is disclosed. Paper is fed into a hopper (11) and transported towards an out feed (81) by a conveyor (13). The flow of the paper is controlled by a barrier (12) constructed from a number of shafts, each holding a number of rotating “stars”. Sensors monitor the operation of the system looking for signs of blockage, feeding information to a controller (63) which alters the speed of the conveyor to maintain the correct flow rate. An additional discharge controlling mechanism (70 – Fig 11) is also disclosed.
Patent NZ-621527-A (NZ)
Title: A genetically modified yeast cell and method of production of recombinant protein or polypeptide thereof
Inventor: WEIS ROLAND
IPC: C12P21/02
Filed: 2012-08-31
Abstract: Disclosed is a genetically modified yeast cell comprising at least one recombinant promoter operably linked to at least one gene encoding a polypeptide or protein supporting the biosynthesis of polypeptides or proteins within the cell, the at least one gene being located at the native genomic locus of the genetically unmodified wild-type yeast cell, wherein the naturally occurring promoter of the at least one gene encoding the biosynthesis supporting polypeptide or protein is inactivated by at least one mutation within the naturally occurring promoter and a secretion cassette comprising a recombinant nucleic acid molecule encoding a protein or polypeptide of interest. Also disclosed is the use of the genetically modified yeast cell in producing a recombinant protein or polypeptide of interest.
Patent NZ-631432-A (NZ)
Title: Scale-inhibiting polymers and methods for preventing scale formation
Inventor: LUCAS MOORE
IPC: C08F228/02
Filed: 2014-04-24
Abstract: Scale-inhibiting polymers, compositions comprising the scale-inhibiting polymers and methods for preventing scale formation in circulating fluid are provided. The scale-inhibiting polymers comprise two or more recurring monomers wherein in at least one recurring monomer is an allyl-sulfonate-containing monomer, and at least one recurring monomer is a styrene-sulfonate-containing monomer. The polymers, compositions and methods may be used in industrial processes including metal extraction from mineral ores
Patent NZ-700332-A (NZ)
Title: Multisubstituted aromatic compounds as inhibitors of thrombin
Inventor: WILLIAMS DAVID CHARLES
IPC: C07D409/14
Filed: 2011-03-30
Abstract: Disclosed is the use of inhibitors of thrombin(activated blood-coagulation factor II, EC 3.4.21.5), which are substituted pyrazolyl or substituted triazolyl compounds, in the treatment of thrombotic conditions such as those that can be treated with anticoagulants.
Patent NZ-702868-A (NZ)
Title: Liquid-spraying device
Inventor: KANNO MINORU
IPC: C02F1/46
Filed: 2013-09-05
Abstract: A base (26) has a discharge outlet (30) for discharging acidic water. The base (26) has a first supply channel (28) communicating with the discharge outlet (30) so as to enable the supply of acidic water and a second supply channel (29) communicating with a plurality of spray orifices (34) so as to enable the supply of alkaline water. The second supply channel (29) is open so that the tip thereof continues entirely around the lateral face of the base (26). The rotation section (27) is rotatably provided along the lateral surface of the base (26). The rotation section (27) has a plurality of spray orifices (34) arranged so as to surround the circumference of the discharge outlet (30). The rotation section (27) has a plurality of communication channels (33) communicating with the spray orifices (34) and the second supply channel (29). The spray orifices (34) spray alkaline water while rotating around the discharge outlet (30) so that a curtain of the alkaline water surrounds the acidic water discharged from the discharge outlet (30).
Patent NZ-704074-A (NZ)
Title: Compositions and processes for downhole cementing operations
Inventor: SHANBHAG RUCHIR M
IPC: E21B33/14
Filed: 2013-02-15
Abstract: The present invention relates to methods of cementing, for example, an oil or gas well. The method may involve pumping a suspension of a filler mixture and at least about 5 weight percent of a thermosetting resin based on the total weight of resin and filler mixture. Advantages may include superior properties and reliability as compared to conventional cementing operations often involving Portland cement.
Patent NZ-705831-A (NZ)
Title: Mixer drum device
Inventor: KASAHARA TETSUO
IPC: B60P3/16
Filed: 2012-09-12
Abstract: A mixer drum device for a mixer truck to agitate a storage object, including a drum rotatably disposed on a vehicle body and configured to have an opening end on one end side and a closure end on another end side, a mixing blade disposed spirally along an inner wall surface of the drum, and a sub-blade extended from an edge portion of the mixing blade toward a center of rotation of the drum. The sub-blade is provided near the opening end of the drum and the sub-blade from the opening end to a predetermined position on a closure end side is configured to have a constant distance between a tip of the sub-blade and the center of rotation of the drum. In the mixer drum device of the concrete mixer truck, the sub-blade that is standingly provided from the edge portion of the mixing blade toward the center of rotation side of the drum is formed at the mixing blade near the opening end of the drum, so that the flow of the ready-mixed concrete toward the opening end side can be dammed up, and the ready-mixed concrete can be prevented from spilling out of the drum, when, for example, the concrete mixer truck starts to move forward. Further, it is not necessary to reduce a load capacity of the ready-mixed concrete or to increase the size of the drum in order to prevent the ready-mixed concrete from spilling out of the drum, and therefore, loading efficiency of the ready-mixed concrete in the drum is not reduced.
Patent NZ-710727-A (NZ)
Title: Stabilized human immunodeficiency virus (hiv) envelope (env) trimer vaccines and methods of using the same
Inventor: BAROUCH DAN
IPC: A61K39/21
Filed: 2014-01-07
Abstract: The invention features stabilized human immunodeficiency virus (HIV) envelope (Env) trimers. In particular, the present invention describes stabilized HIV envelope trimers comprising three modified gp140 polypeptides. Each modified gp140 polypeptide comprises the specific modifications of (i) introduction of two cleavage site point mutations 507E and 514E (ii) a factor Xa site SRIEGR and (iii) a T4-fibritin “foldon” trimerization domain after the factor Xa site. These modifications achieve increased stability of the timer. The invention also features vaccines, nucleic acids, and vectors to deliver and/or facilitate production of the stabilized HIV Env trimers. In addition, the invention features methods of making and using the stabilized HIV Env trimers of the invention as vaccines.